| | Lupus Study |
Ongoing |
30 Sep 2019 |
| | OLYMPUS - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Roxadustat for the Treatment of Anemia in Chronic Kidney Disease Patients . . . |
Completed |
20 May 2020 |
| | Open-label Extension Study of Relamorelin for the Treatment of Diabetic Gastroparesis |
Pending |
13 Jul 2020 |
| | Open-label, randomised controlled trial of Efepoetin Alfa for treatment of Anemia associated with Chronic Kidney Disease Patients Not On Dialysis (ND-CKD). A non-inferiority trial compared to Methoxy . . . |
Ongoing |
14 Aug 2020 |
| | Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients with Multidrug Resistant Tuberculosis . . . |
Completed |
04 Mar 2020 |
| | Post-Authorization Safety Study: Cohort Event monitoring for Dengvaxia, CYD-TDV Dengue Vaccine |
Ongoing |
02 Jul 2020 |
| | Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines . . . |
Completed |
02 Jul 2020 |
| | Randomized Sitagliptin Withdrawal Study (MK-0431-845) |
Completed |
23 May 2019 |
| | Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess Cardiovascular Outcomes Following Treatment With Ertugliflozin (MK-8835/PF-04971729) in Subjects with Type 2 Diabetes Melli . . . |
Completed |
14 Aug 2020 |
| | RE-COVERY DVT/PE: global study on treatment and secondary prevention of acute venous thromboembolism |
Completed |
02 Dec 2019 |
| | ROCKIES - A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of the Safety and Efficacy of Roxadustat in the Treatment of Anemia in Dialysis Patients . . . |
Completed |
20 May 2020 |
| | ROSuvastatin Evaluation as a Tuberculosis Treatment Adjunct |
Pending |
29 Oct 2020 |
| | Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents with Type 2 Diabetes . . . |
Completed |
14 Aug 2020 |
| | Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021) . . . |
Pending |
26 Feb 2020 |
| | Sangobion®Iron+ Non-Interventional Study to Evaluate Changes in Hemoglobin Status in Subjects with Mild to Moderate Iron Deficiency Anemia (SANOIN Study) . . . |
Ongoing |
13 Apr 2020 |
| | Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia |
Completed |
30 Jun 2020 |
| | Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially with Adacel® in Healthy Subjects . . . |
Ongoing |
02 Jul 2020 |
| | Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care . . . |
Pending |
27 Aug 2019 |
| | Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Subjects With Advanced HCC Who Have Not Received Previous Systemic Anticancer Therapy . . . |
Ongoing |
25 Jun 2019 |
| | Study of cefiderocol or standard of care for paediatric patients with confirmed or suspected Gram-negative bacterial infections receiving a single dose and paediatric patients with confirmed or suspec . . . |
Pending |
02 Mar 2020 |
| | Study of MK-3475 (Pembrolizumab) Versus Platinum-based Chemotherapy for Participants With PD-L1-positive Advanced or Metastatic Non-small Cell Lung Cancer (MK-3475-042/KEYNOTE-042) . . . |
Ongoing |
24 May 2019 |
| | Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240) . . . |
Completed |
12 Mar 2020 |
| | Study to demonstrate the efficacy, safety and tolerability of intravenous secukinumab up to 52 weeks in subjects with active Psoriatic Arthritis . . . |
Ongoing |
04 Jun 2020 |
| | The Efficacy and Safety of Bimatoprost SR in Patients with Open-Angle Glaucoma or Ocular Hypertension . . . |
Completed |
27 Feb 2020 |
| | The short term effects of Biomechanical Taping on fascia slide on extensor digitorum communis, electromyographic activities of upper extremity muscles, static maximum handgrip strength, lateral elbow . . . |
Ongoing |
06 Oct 2020 |
